Emotional stress and immunotherapy for liver cancer
Part of Cancer, Digestive system clinical trials.
This study looks at how emotional stress affects how well immunotherapy works for liver cancer. It is for people with liver cancer who are about to start immunotherapy, either before or after surgery, or as first treatment for advanced cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with liver cancer that can't be removed with surgery, or you will have surgery for liver cancer
- Your liver is working well (Child-Pugh class A)
- You are able to walk and take care of yourself (ECOG score 0 or 1)
- You are not currently taking medicine for depression or anxiety
- You can fill out questionnaires about your emotions and stress
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether psychological stress changes how well lung cancer treatments work and what the outlook is. You may qualify if you’re about to start (or recently started) certain immunotherapy-based treatments, and you can complete stress and well-being questionnaires.
This study looks at how well a combination of liver-directed therapy and immunotherapy works for people with liver cancer that cannot be removed by surgery. It aims to find markers in your blood that might predict if the treatment will shrink the tumor enough to allow surgery later.
This trial tests whether taking a probiotic before surgery together with immunotherapy can improve outcomes for people with liver cancer that can be removed. You must be able to have surgery after the combination treatment.
This trial studies how emotional well-being affects how well immunotherapy works for liver cancer. It is for people newly diagnosed with liver cancer who have not yet been treated.
This trial studies if emotional health affects how well targeted therapy and immunotherapy work for people with advanced liver cancer. You will receive chemotherapy directly into the liver along with targeted drugs and immunotherapy.
This study looks at whether chronic stress changes how well immunotherapy (ICI therapy) works in people with esophageal cancer. It may help doctors understand who benefits most from treatment and how stress could affect outcomes.
Hear when a new Psychological Distress trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.